Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
Clinical trial NCT07400523 · RECRUITING
Trial details
- NCT number
- NCT07400523
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-10
- Primary completion
- 2030-02-10
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.